Bai SR - Search Results

1

Clinical efficacy of ticagrelor in patients undergoing emergency intervention for acute myocardial infarction and its impact on platelet aggregation rate.

Wu HB, Tian HP, Wang XC, Bai SR, Li XN, Zhang LN, Du RP. Wu HB, et al. Among authors: bai sr. Am J Transl Res. 2018 Jul 15;10(7):2175-2183. eCollection 2018. Am J Transl Res. 2018. PMID: 30093954 Free PMC article.

2

Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention.

Wei LY, Fu XH, Li W, Bi XL, Bai SR, Xing K, Wang YB. Wei LY, et al. Among authors: bai sr. Chin Med J (Engl). 2015 May 5;128(9):1147-50. doi: 10.4103/0366-6999.156078. Chin Med J (Engl). 2015. PMID: 25947394 Free PMC article. Clinical Trial.

3

Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.

Wang X, Li X, Wu H, Li R, Liu H, Wang L, Bai S, Zhang L, Chen T, Liu J, Li Q, Du R. Wang X, et al. Coron Artery Dis. 2019 Aug;30(5):317-322. doi: 10.1097/MCA.0000000000000707. Coron Artery Dis. 2019. PMID: 30614823 Clinical Trial.

4

Predictive value of soluble suppression of tumourigenicity 2 on myocardial reperfusion.

Bai S, Liu H, Wu H, Wang X, Li R, Li X, Li X, Zhang L, Chen T, Du R. Bai S, et al. Intern Med J. 2020 Aug;50(8):985-992. doi: 10.1111/imj.14639. Intern Med J. 2020. PMID: 31566840

5

Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden.

Wang X, Liu H, Wu H, Xiao Y, Bai S, Li X, Li X, Zhang L, Chen T, Li H, Liu J, Du R. Wang X, et al. Coron Artery Dis. 2020 Sep;31(6):493-499. doi: 10.1097/MCA.0000000000000853. Coron Artery Dis. 2020. PMID: 32073417

6

Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.

Bai S, Wang X, Wu H, Chen T, Li X, Zhang L, Li X, Er L, Du R. Bai S, et al. Eur J Pharmacol. 2021 Jun 15;901:174095. doi: 10.1016/j.ejphar.2021.174095. Epub 2021 Apr 20. Eur J Pharmacol. 2021. PMID: 33862063

7

Triglyceride glucose index is a risk factor for heart failure: A prospective cohort study.

Jia Y, Zhang Y, Bai S, Liu J, Chen T, Liu X, Xu C, Zhang R, Du R. Jia Y, et al. ESC Heart Fail. 2024 Jul 17. doi: 10.1002/ehf2.14963. Online ahead of print. ESC Heart Fail. 2024. PMID: 39016168 Free article.

8

Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.

Fan Y, Jiang Y, Fu X, Cai J, Wang Y, Li W, Gu X, Xing K, Bai S, Bi X. Fan Y, et al. Coron Artery Dis. 2015 Dec;26(8):671-7. doi: 10.1097/MCA.0000000000000294. Coron Artery Dis. 2015. PMID: 26267747 Clinical Trial.

9

Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Chen C, Fu X, Li W, Jia X, Bai S, Geng W, Xing K. Chen C, et al. Exp Ther Med. 2015 Sep;10(3):1059-1065. doi: 10.3892/etm.2015.2623. Epub 2015 Jul 7. Exp Ther Med. 2015. PMID: 26622439 Free PMC article.

10

Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.

Bai S, Fu X, Gu X, Wang Y, Li W, Fan Y, Wei L, Bi X. Bai S, et al. Coron Artery Dis. 2016 Jun;27(4):302-10. doi: 10.1097/MCA.0000000000000366. Coron Artery Dis. 2016. PMID: 26945186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters